Safety and Pharmacokinetics Study of MBX 2109 in Adult Subjects With Normal and Impaired Renal Function

Completed · Phase 1

Conditions studied: Renal Impairment

In brief

Evaluate the Safety and Pharmacokinetics of MBX 2109 in Adult Subjects with Normal and Impaired Renal Function

Key facts

Study ID

NCT06496217

Run by

MBX Biosciences

People needed

25

Starts

2024-06-13

Expected to finish

2025-09-04

Last updated by the study team

2025-10-28

Who can join

Age: 18 and older, up to 80. Sex: any. Healthy volunteers: accepted.

Where it is running

• MBX Biosciences Investigational Site — Miami, Florida, United States
• MBX Bioscience Investigational Site — Tampa, Florida, United States
• MBX Biosciences Investigational Site — Minneapolis, Minnesota, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.